Search Results - "Kozma, Sam"

Use of anti-viral therapies in hospitalised COVID-19 patients in the United Arab Emirates: a cost-effectiveness and health-care resource use analysis by Subhi, Ahmad, Shamy, Amin Mohamed El, Hussein, Saeed Abdullah Mohammed, Jarrett, James, Kozma, Sam, Harfouche, Camille, Al Dallal, Sara

“…This study attempts to estimate the cost-effectiveness of the antiviral remdesivir, as recommended in the 2021 COVID treatment guidelines for the United Arab…”
Get full text

Long-term health and economic benefits of switching to tenofovir alafenamide versus continuing on entecavir in chronic hepatitis B patients with low-level viremia in Saudi Arabia by Sanai, Faisal M, Aljawad, Mohammed, Alghamdi, Abdullah Saeed, Yehoshua, Alon, Khathlan, Abdullah, Alghamdi, Mohammed, Kozma, Sam, Smith, Nathaniel, El-Moustaid, Fadoua, Jeyakumar, Sushanth, Kachru, Nandita

“…Despite the success of current treatments, many chronic hepatitis B (CHB) patients still live with low-level viremia [LLV] resulting in liver disease…”
Get full text

Hepatitis B care pathway in Jordan: current situation, gaps and recommended actions by Nusair, Majed, Rayyan, Yaser, Hammoudeh, Waseem, Al-Khatib, Mohammed Amer, Mansour, Eid, Snehanshu, Snehanshu, Bassil, Nathalie, Kozma, Sam, Ghazzawi, Imad Al

“…Objectives: Hepatitis B virus (HBV) infection remains a worldwide public health problem. The last major review of the HBV care pathway in the Middle East was…”
Get full text

The estimation of direct hospital costs and Intensive Care Units (ICU) admissions for COVID-19 patients and the assessment of the impact of remdesivir administration in the Saudi Arabian context by Ruggeri, Matteo, Signorini, Alessandro, Caravaggio, Silvia, Alraddadi, Basem, Alali, Alaa, Kozma, Sam, Harfouche, Camille, AlMusawi, Tariq

Get full text

Modeling the Potential Impact of Remdesivir Treatment for Hospitalized Patients with COVID-19 in Saudi Arabia on Healthcare Resource Use and Direct Hospital Costs: A Hypothetical Study by Ruggeri, Matteo, Signorini, Alessandro, Caravaggio, Silvia, Alraddadi, Basem, Alali, Alaa, Jarrett, James, Kozma, Sam, Harfouche, Camille, Al Musawi, Tariq

“…Background and Objectives Coronavirus disease 2019 (COVID-19) has spread rapidly worldwide. Saudi Arabia was significantly impacted by COVID-19. In March 2021,…”
Get full text

Real-world management of non-alcoholic steatohepatitis differs from clinical practice guideline recommendations and across regions by Anstee, Quentin M., Hallsworth, Kate, Lynch, Niall, Hauvespre, Adrien, Mansour, Eid, Kozma, Sam, Marino, John-Paul, Bottomley, Juliana, Piercy, James, Higgins, Victoria

“…Despite availability of diagnostic and management reference guidelines outlining standard of care for patients with non-alcoholic fatty liver disease (NAFLD)…”
Get full text

Cost Effectiveness of Screening for Hepatitis C Virus in Iraq in the Era of Simplified Testing and Treatment by Asker, Bassem, Jawad, Raghad, Asreah, Rabah, Jamal, Haydar, Jassem, Ahmed, Inaya, Muslim Abdelkareem, Baker, Hiwa Abou, Kozma, Sam, Mansour, Eid, McNamara, Bryony, Miller, Ryan, Darlington, Oliver, McEwan, Phil, Sugrue, Daniel M., Jarallah, Haidar

“…Background and Objective Recent advances in hepatitis C virus (HCV) diagnostic testing methods allow for a one-stop simplified ‘test and cure’ approach. The…”
Get full text

Clinical and economic burden of nonalcoholic steatohepatitis in Saudi Arabia, United Arab Emirates and Kuwait by Sanai, Faisal M., Al Khathlan, Abdullah, Al Fadhli, Ahmad, Jazzar, Ahmad S., Hashim, Al Moutaz, Mansour, Eid, Abaalkhail, Faisal, Hasan, Fuad, Al Mudaiheem, Hajer, Al Quraishi, Huda, Bottomley, Juliana, Alswat, Khalid A., Al Ghamdi, Mohammed, Farghaly, Mohamed, Fathy, Motaz, Awad, Nancy, Mohamed, Omneya, Kozma, Sam, Al-Hamoudi, Waleed, Al-jedai, Ahmed

“…Background and aims The Middle East (ME) has a high prevalence of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH), driven by…”
Get full text

Alignment of Physician-Stated vs Clinically Derived Reference Fibrosis Score in Patients with Non-Alcoholic Steatohepatitis: A Real-World European Survey by Anstee, Quentin M, Hallsworth, Kate, Lynch, Niall, Hauvespre, Adrien, Mansour, Eid, Kozma, Sam, Bottomley, Juliana, Milligan, Gary, Piercy, James, Higgins, Victoria

“…Stratifying disease severity in patients with non-alcoholic steatohepatitis (NASH) is essential for appropriate treatment and long-term management. Liver…”
Get full text

Hepatitis B Care Pathway in the United Arab Emirates: Current Situation, Gaps, and Actions by Al Zaabi, Mohamed, Al Quraishi, Huda, Al Rifai, Ahmad, Abdelaziz, Moustafa, Mansour, Eid, Snehanshu, Snehanshu, Bassil, Nathalie, Kozma, Sam, Taha, Mazen

“…Introduction: Hepatitis B virus (HBV) infection remains a worldwide public health problem. The last major review of the epidemiology and management of HBV in…”
Get full text

Hepatitis B Care Pathway in the United Arab Emirates: Current Situation, Gaps, and Actions by Mohamed Al Zaabi, Huda Al Quraishi, Ahmad Al Rifai, Moustafa Abdelaziz, Eid Mansour, Snehanshu Snehanshu, Nathalie Bassil, Sam Kozma, Mazen Taha

“…Introduction: Hepatitis B virus (HBV) infection remains a worldwide public health problem. The last major review of the epidemiology and management of HBV in…”
Get full text

Software tools are never a substitute for competency by Kozma, Sam

“…Certainly the growing number of safety life cycle software tools helps ensure that the math is done correctly and consistently and that transcription errors…”
Get full text